
![]()
Imaging
The Global Imaging Group focuses on deepening the understanding of a drug’s action on the body or a tissue. The group uses a broad range of imaging methods in animal studies including whole body imaging and optical imaging using bioluminescent probes.
Imaging allows for non-invasive, quantitative evaluation of a drug’s action on disease while at the same time reducing the number of animals needed in an experiment.
The group also images cells using probes known as biomarkers to help image specific targets within the cell. Cellular imaging can be incorporated into high through-put screening to determine the timing and location of molecular activity within individual cells.
The Global Imaging Group uses imaging techniques in animal studies for whole body imaging (PET, MRI, CT, and SPECT) and for optical imaging (bioluminescent probes) as well as performs cellular imaging.
Disease areas
Understanding the underlying molecular basis of disease has enabled NIBR to turn scientific insights into medical breakthroughs.
Clinical sciences

Incorporating clinical medicine into its early stage "benchtop" drug discovery.